Importance of a c-Myb binding site for lymphomagenesis by the retrovirus SL3-3

Journal of Virology

Volumn 71, Issue 2, 1997, Pages 1213-1219

  Nieves, Angel ^a   Levy, Laura S ^b   Lenz, Jack ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; BINDING SITE; CONTROLLED STUDY; ENHANCER REGION; MOLONEY LEUKEMIA ONCOVIRUS; MOUSE; MURINE LEUKEMIA VIRUS; NONHUMAN; ONCOGENE C MYB; PRIORITY JOURNAL; PROMOTER REGION; T CELL LYMPHOMA; T LYMPHOCYTE; VIRUS CARCINOGENESIS; VIRUS VIRULENCE;

EID: 0031014019     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.2.1213-1219.1997     Document Type: Article

References (45)

1. Athas, G., B. Choi, S. Prabhu, P. Lobelle-Rich, and L. S. Levy. 1995. Genetic determinants of feline leukemia virus-induced multicentric lymphomas. Virology 214:431-438.
2. Bae, S. C., Y. Yamaguchi-Iwai, E. Ogawa, M. Maruyama, M. Inuzuka, H. Kagoshima, K. Shigesada, M. Satake, and Y. Ito. 1993. Isolation of PEBP2αB cDNA representing the mouse homolog of human acute myeloid leukemia gene, AML1. Oncogene 8:809-814.
3. Boral, A. L., S. A. Okenquist, and J. Lenz. 1989. Identification of the SL3-3 virus enhancer core as a T-lymphoma cell-specific element. J. Virol. 63:76-84.
4. Brightman, B. K., A. Rein, D. J. Trepp, and H. Fan. 1991. An enhancer variant of Moloney murine leukemia virus defective in leukemogenesis does not generate mink cell focus-inducing virus in vivo. Proc. Natl. Acad. Sci. USA 88:2264-2268.
5. Celander, D., and W. A. Haseltine. 1987. Glucocorticoid regulation of murinc leukemia virus transcription elements is specified by determinants within the viral enhancer region. J. Virol. 61:269-275.
6. Chatis, P. A., C. A. Holland, J. W. Hartley, W. P. Rowe, and N. Hopkins. 1983. Role for the 3′ end of the genome in determining disease specificity of Friend and Moloney murine leukemia viruses. Proc. Natl. Acad. Sci. USA 80:4408-4411.
7. Chatis, P. A., C. A. Holland, J. E. Silver, T. N. Frederickson, N. Hopkins, and J. W. Hartley. 1984. A 3′ end fragment encompassing the transcriptional enhancers of nondefective friend virus confers erythroleukemogenicity on Moloney leukemia virus. J. Virol. 52:248-254.
8. Comer, K. A., H. L. Morrison, and J. Lenz. Induction of transcripts from both major promoters of c-myc by the long terminal repeat enhancer of a T-cell lymphomagenic retrovirus. Submitted for publication.
9. Corneliussen, B., A. Thornell, B. Hallberg, and T. Grundström. 1991. Helix-loop-helix transcriptional activators bind to a sequence in glucocorticoid response elements of retrovirus enhancers. J. Virol. 65:6084-6093.
10. DesGroseillers, L., and P. Jolicoeur. 1984. The tandem direct repeats within the long terminal repeat of murine leukemia viruses are the primary determinant of their leukemogenic potential. J. Virol. 52:945-952.
11. DesGroseillers, L., E. Rassart, and P. Jolicoeur. 1983. Thymotropism of murine leukemia virus is conferred by its long terminal repeat. Proc. Natl. Acad. Sci. USA 80:4203-4207.
12. Goff, S., P. Traktman, and D. Baltimore. 1996. Isolation and properties of Moloney murine leukemia virus mutants: use of a rapid assay for release of virion reverse transcriptase. J. Virol. 38:239-248.
13. Golemis, E., Y. Li, T. N. Fredrickson, J. W. Hartley, and N. Hopkins. 1989. Distinct segments within the enhancer region collaborate to specify the type of leukemia induced by nondefective Friend and Moloney viruses. J. Virol. 63:328-337.
14. Golemis, E. A., N. A. Speck, and N. Hopkins. 1990. Alignment of U3 sequences of mammalian type C viruses: identification of highly conserved motifs and implications for enhancer design. J. Virol. 64:534-542.
15. Hallberg, B., J. Schmidt, A. Luz, F. S. Pedersen, and T. Grundström. 1991. SL3-3 enhancer factor 1 transcriptional activators are required for tumor formation by SL3-3 murine leukemia virus. J. Virol. 65:4177-4181.
16. Hedrick, S. M., D. I. Cohen, E. A. Nielsen, and M. M. Davis. 1984. Isolation of cDNA clones encoding T cell-specific membrane-associated proteins. Nature 308:149-153.
17. Ishimoto, A., M. Takimoto, A. Adachi, M. Kakuyama, S. Kato, K. Kakimi, K. Fukuoka, T. Ogiu, and M. Matsuyama. 1987. Sequences responsible for erythroid and lymphoid leukemia in the long terminal repeats of Friend mink cell focus-forming and Moloney murine leukemia viruses. J. Virol. 61:1861-1866.
18. Kamachi, Y., E. Ogawa, M. Asano, S. Ishida, Y. Murakami, M. Satake, Y. Ito, and K. Shigesada. 1990. Purification of a mouse nuclear factor that binds to both the A and B cores of the polyomavirus enhancer. J. Virol. 4808-4819.
19. Lawrenz-Smith, S. C, A. C. Massey, D. J. Innes, and C. Y. Thomas. 1995. Pathogenic determinants in the U3 region of recombinant murine leukemia viruses isolated from CWD and HRS/J mice. J. Virol. 68:5174-5183.
20. Lenz, J., D. Celander, R. L. Crowther, R. Patarca, D. W. Perkins, and W. A. Haseltine. 1984. Determination of the leukemogenicity of a murine retrovirus by sequences within the long terminal repeat. Nature 308:467-470.
21. Li, Y., E. Golemis, J. W. Hartley, and N. Hopkins. 1987. Disease specificity of nondefective Friend and Moloney murine leukemia viruses is controlled by a small number of nucleotides. J. Virol. 61:693-700.
22. Li, Y., C. A. Holland, J. W. Hartley, and N. Hopkins. 1984. Viral integration near c-myc in 10-20% of MCF 247-induced AKR lymphomas. Proc. Natl. Acad. Sci. USA 81:6808-6811.
23. LoSardo, J., A. Nieves, and J. Lenz. 1996. Unpublished results.
24. LoSardo, J. E., A. L. Boral, and J. Lenz. 1990. Relative importance of elements within the SL3-3 virus enhancer for T-cell specificity. J. Virol. 64:1756-1763.
25. Manley, N. R., M. O'Connell, W. Sun, N. A. Speck, and N. Hopkins. 1993. Two factors that bind to highly conserved sequences in mammalian type C retroviral enhancers. J. Virol. 67:1967-1975.
26. Morrison, H. L., H. Y. Dai, F. S. Pedersen, and J. Lenz. 1991. Analysis of the significance of two single-base-pair differences in the SL3-3 and Akv virus long terminal repeats. J. Virol. 65:1019-1022.
27. Morrison, H. L., B. Soni, and J. Lenz. 1995. Long terminal repeat enhancer core sequences in proviruses adjacent to C-myc in T-cell lymphomas induced by a murine retrovirus. J. Virol. 69:446-455.
28. Nielsen, A. L., N. Pallisgaard, F. S. Pedersen, and P. Jorgensen. 1996. Basic helix-loop-helix proteins in murine type C retrovirus transcriptional regulation. J. Virol. 68:5638-5647.
29. Nieves, A., and J. Lenz. Unpublished data.
30. O'Donnell, P. V., E. Fleissner, H. Lonial, C. Koehne, and A. Reicin. 1985. Early clonality and high-frequency proviral integration into the c-myc locus in AKR leukemia. J. Virol. 55:500-503.
31. Ogawa, E., M. Maruyama, H. Kagoshima, M. Inuzuka, J. Lu, M. Satake, K. Shigesada, and Y. Ito. 1993. PEBP2/PEA2 represents a family of transcription factors homologous to the products of the Drosophila runt gene and the human AML1 gene. Proc. Nail. Acad. Sci. USA 90:6859-6863.
32. Reicin, A., J.-Q. Yang, K. B. Marcu, E. Fleissner, C. F. Koehne, and P. V. O'Donnell. 1986. Deregulation of the c-myc oncogene in virus-induced thymic lymphomas of AKR/J mice. Mol. Cell. Biol. 6:4088-4092.
33. Rosen, C. A., W. A. Haseltine, J. Lenz, R. Ruprecht, and M. W. Cloyd. 1985. Tissue selectivity of murine leukemia virus infection is determined by long terminal repeat sequences. J. Virol. 55:862-866.
34. Rowe, W. P., W. E. Pugh, and J. W. Hartley. 1970. Plaque assay techniques for murine leukemia viruses. Virology 12:1136-1139.
35. Selten, G., H. T. Cuypers, M. Zijlstra, C. Melief, and A. Berns. 1984. Involvement of c-myc in MuLV induced T-cell lymphomas in mice: frequency and mechanisms of activation. EMBO 3:3215-3222.
36. Short, M. K., S. A. Okenquist, and J. Lenz. 1987. Correlation of leukcmogenic potential of murine retroviruses with transcriptional tissue preference of the viral long terminal repeats. J. Virol. 61:1067-1072.
37. Speck, N. A., and D. Baltimore. 1987. Six distinct nuclear factors interact with the 75-base-pair repeat of the Moloney murine leukemia virus enhancer. Mol. Cell. Biol. 7:1101-1110.
38. Speck, N. A., B. Renjifo, E. Golemis, T. Fredrickson, J. Hartley, and N. Hopkins. 1990. Mutation of the core or adjacent LVb elements of the Moloney murine leukemia virus enhancer alters disease specificity. Genes Dev. 4:233-242.
39. Sun, W., B. J. Graves, and N. A. Speck. 1995. Transactivation of the Moloney murine leukemia virus and T-cell receptor β-chain enhancers by chf and ets requires intact binding sites for both proteins. J. Virol. 69:4941-4949.
40. Thornell, A., B. Hallberg, and T. Grundström. 1988. Differential protein binding in lymphocytes to a sequence in the enhancer of the mouse retrovirus SL3-3. Mol. Cell. Biol. 8:1625-1637.
41. Thornell, A., B. Hallberg, and T. Grundström. 1991. Binding of SL3-3 enhancer factor 1 transcriptional activators to viral and chromosomal enhancer sequences. J. Virol. 65:42-50.
42. Weaver, D., F. Constantini, T. Imanishi-Kari, and D. Baltimore. 1985. A transgenic immunoglobulin mu gene prevents rearrangements of endogenous genes. Cell 42:117-127.
43. Wotton, D., J. Ghysdael, S. Wang, N. A. Speck, and M. J. Owen. 1994. Cooperative binding of ets-1 and core binding factor to DNA. Mol. Cell. Biol. 14:840-850.
44. Zaiman, A. L., and J. Lenz. 1996. Transcriptional activation of a retrovirus enhancer by CBF (AML1) requires a second factor: evidence for cooperativity with c-Myb. J. Virol. 70:5618-5629,
45. Zaiman, A. L., A. F. Lewis, B. E. Crute, N. A. Speck, and J. Lenz. 1995. Transcriptional activity of core binding factor α (AML1) and β subunit on murine leukemia virus enhancer cores. J. Virol. 69:2898-2906.